Get the Stockscreener App
0.38
0.96%
0.0036
Vyne Therapeutics Inc stock is traded at $0.38, with a volume of 368.63K.
It is up +0.96% in the last 24 hours and up +12.46% over the past month.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
See More
Previous Close:
$0.3764
Open:
$0.383
24h Volume:
368.63K
Relative Volume:
0.19
Market Cap:
$12.65M
Revenue:
$476.00K
Net Income/Loss:
$-38.52M
P/E Ratio:
-0.4203
EPS:
-0.9041
Net Cash Flow:
$-39.89M
1W Performance:
-1.40%
1M Performance:
+12.46%
6M Performance:
-62.00%
1Y Performance:
-85.16%
1-Day Range:
$0.3656
$0.3892
1-Week Range:
$0.35
$0.3892
52-Week Range:
$0.2805
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Name
Vyne Therapeutics Inc
Sector
Industry
Phone
800-775-7936
Address
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Compare VYNE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.38 | 12.46M | 476.00K | -38.52M | -39.89M | -0.9041 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.06 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
717.70 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.07 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.75 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.43 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-18-24 | Initiated | BTIG Research | Buy |
| Dec-06-21 | Resumed | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Stock (VYNE) Latest News
Can VYNE Therapeutics Inc. stock resist sector downturnsTrade Exit Summary & Low Risk Profit Maximizing Plans - Newser
VYNE Therapeutics (NASDAQ:VYNE) Shares Down 1.6% – What’s Next? - Defense World
Is VYNE Therapeutics Inc (VYNE) positioned for future growth? - Setenews
Can VYNE Therapeutics Inc. stock sustain market leadershipWeekly Earnings Recap & AI Powered Buy/Sell Recommendations - newser.com
Will VYNE Therapeutics Inc. stock continue dividend increasesVolume Spike & Fast Moving Stock Watchlists - newser.com
Why analysts remain bullish on VYNE Therapeutics Inc. stockWeekly Trade Summary & Low Risk Growth Stock Ideas - newser.com
Is VYNE Therapeutics Inc. stock near bottom after declinePortfolio Gains Report & Consistent Profit Trade Alerts - newser.com
Will VYNE Therapeutics Inc. stock benefit from sector rotationTake Profit & Risk Adjusted Swing Trade Ideas - newser.com
Can VYNE Therapeutics Inc. stock withstand economic slowdownEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
How VYNE Therapeutics Inc. stock performs during Fed tightening cyclesJuly 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Understanding VYNE Therapeutics Inc.’s price movementProfit Target & Free Growth Oriented Trading Recommendations - newser.com
Will VYNE Therapeutics Inc. stock maintain momentum in 2025Portfolio Gains Report & Risk Controlled Stock Pick Alerts - newser.com
What high frequency data says about VYNE Therapeutics Inc.Trade Exit Report & Growth Focused Entry Reports - newser.com
Signal strength of VYNE Therapeutics Inc. stock in tech scannersMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Is VYNE Therapeutics Inc. showing signs of accumulationJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
What Wall Street predicts for VYNE Therapeutics Inc. stock price2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Tools to monitor VYNE Therapeutics Inc. recovery probabilityMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com
Can swing trading help recover from VYNE Therapeutics Inc. lossesEarnings Risk Summary & High Accuracy Buy Signal Tips - newser.com
Vyne Therapeutics Inc Stock (VYNE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):